Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Limited

Explore clinical trials studying Scleroderma, Limited. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Scleroderma, Limited trial results

Completed

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

NCT00775463

Conditions
Connective Tissue Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • University of Alabama - Arthritis Clinical Intervention Program Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Stanford University School of Medicine/Palo Alto VA Health Care System Palo Alto, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details

Related conditions